Evaluation of the Importance of Hydrophobic Interactions in Drug Binding to Dihydrofolate Reductase

Kazunari Taira, Stephen J. Benkovic

Research output: Contribution to journalArticle

82 Citations (Scopus)

Abstract

The interaction of dihydrofolate reductase (DHFR) from Escherichia coli with drugs such as methotrexate (MTX)and 2, 4-diamino-6, 7-dimethylpteridine (DAM) has been studied by means of site-directed mutagenesis, fluorescence spectroscopy, and steady-state as well as transient kinetics. A strictly conserved residue at the dihydrofolate binding site of DHFR, phenylalanine-31, has been replaced with tyrosine or valine to ascertain the importance for binding of this hydrophobic amino acid, which interacts with both the pteridine ring and the p-aminobenzoyl moiety. The first mutation (Phe-31 → Tyr) has a minimal effect on the binding of the classical inhibitor, DAM. On the other hand, the second mutation (Phe-31 → Val) has increased the dissociation constant of DAM from the DHFR.NADPH.DAM ternary complex over 150-fold (>3 kcal/mol). The dissociation constant of DAM from the (Val31-DHFR). DAM binary complex was too large to be measured fluorometrically. More importantly, these mutations have decreased the overall tight binding of MTX, from 100- to 140-fold (corresponding to a loss of binding energy of 2.2-2.4 kcal/mol) for the Tyr-31 and Val-31 mutants, respectively. These results indicate that hydrophobic interactions between MTX and DHFR are at least as important as formation of the MTX.DHFR salt bridge in the tight binding of MTX.

Original languageEnglish (US)
Pages (from-to)129-137
Number of pages9
JournalJournal of Medicinal Chemistry
Volume31
Issue number1
DOIs
StatePublished - Jan 1 1988

Fingerprint

Tetrahydrofolate Dehydrogenase
Hydrophobic and Hydrophilic Interactions
Methotrexate
Pharmaceutical Preparations
Mutation
Pteridines
Fluorescence Spectrometry
Valine
Site-Directed Mutagenesis
Phenylalanine
NADP
Tyrosine
Salts
Binding Sites
Escherichia coli
Amino Acids

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Cite this

@article{112edda991a7444faf08d35908b57eaf,
title = "Evaluation of the Importance of Hydrophobic Interactions in Drug Binding to Dihydrofolate Reductase",
abstract = "The interaction of dihydrofolate reductase (DHFR) from Escherichia coli with drugs such as methotrexate (MTX)and 2, 4-diamino-6, 7-dimethylpteridine (DAM) has been studied by means of site-directed mutagenesis, fluorescence spectroscopy, and steady-state as well as transient kinetics. A strictly conserved residue at the dihydrofolate binding site of DHFR, phenylalanine-31, has been replaced with tyrosine or valine to ascertain the importance for binding of this hydrophobic amino acid, which interacts with both the pteridine ring and the p-aminobenzoyl moiety. The first mutation (Phe-31 → Tyr) has a minimal effect on the binding of the classical inhibitor, DAM. On the other hand, the second mutation (Phe-31 → Val) has increased the dissociation constant of DAM from the DHFR.NADPH.DAM ternary complex over 150-fold (>3 kcal/mol). The dissociation constant of DAM from the (Val31-DHFR). DAM binary complex was too large to be measured fluorometrically. More importantly, these mutations have decreased the overall tight binding of MTX, from 100- to 140-fold (corresponding to a loss of binding energy of 2.2-2.4 kcal/mol) for the Tyr-31 and Val-31 mutants, respectively. These results indicate that hydrophobic interactions between MTX and DHFR are at least as important as formation of the MTX.DHFR salt bridge in the tight binding of MTX.",
author = "Kazunari Taira and Benkovic, {Stephen J.}",
year = "1988",
month = "1",
day = "1",
doi = "10.1021/jm00396a019",
language = "English (US)",
volume = "31",
pages = "129--137",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "1",

}

Evaluation of the Importance of Hydrophobic Interactions in Drug Binding to Dihydrofolate Reductase. / Taira, Kazunari; Benkovic, Stephen J.

In: Journal of Medicinal Chemistry, Vol. 31, No. 1, 01.01.1988, p. 129-137.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Evaluation of the Importance of Hydrophobic Interactions in Drug Binding to Dihydrofolate Reductase

AU - Taira, Kazunari

AU - Benkovic, Stephen J.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The interaction of dihydrofolate reductase (DHFR) from Escherichia coli with drugs such as methotrexate (MTX)and 2, 4-diamino-6, 7-dimethylpteridine (DAM) has been studied by means of site-directed mutagenesis, fluorescence spectroscopy, and steady-state as well as transient kinetics. A strictly conserved residue at the dihydrofolate binding site of DHFR, phenylalanine-31, has been replaced with tyrosine or valine to ascertain the importance for binding of this hydrophobic amino acid, which interacts with both the pteridine ring and the p-aminobenzoyl moiety. The first mutation (Phe-31 → Tyr) has a minimal effect on the binding of the classical inhibitor, DAM. On the other hand, the second mutation (Phe-31 → Val) has increased the dissociation constant of DAM from the DHFR.NADPH.DAM ternary complex over 150-fold (>3 kcal/mol). The dissociation constant of DAM from the (Val31-DHFR). DAM binary complex was too large to be measured fluorometrically. More importantly, these mutations have decreased the overall tight binding of MTX, from 100- to 140-fold (corresponding to a loss of binding energy of 2.2-2.4 kcal/mol) for the Tyr-31 and Val-31 mutants, respectively. These results indicate that hydrophobic interactions between MTX and DHFR are at least as important as formation of the MTX.DHFR salt bridge in the tight binding of MTX.

AB - The interaction of dihydrofolate reductase (DHFR) from Escherichia coli with drugs such as methotrexate (MTX)and 2, 4-diamino-6, 7-dimethylpteridine (DAM) has been studied by means of site-directed mutagenesis, fluorescence spectroscopy, and steady-state as well as transient kinetics. A strictly conserved residue at the dihydrofolate binding site of DHFR, phenylalanine-31, has been replaced with tyrosine or valine to ascertain the importance for binding of this hydrophobic amino acid, which interacts with both the pteridine ring and the p-aminobenzoyl moiety. The first mutation (Phe-31 → Tyr) has a minimal effect on the binding of the classical inhibitor, DAM. On the other hand, the second mutation (Phe-31 → Val) has increased the dissociation constant of DAM from the DHFR.NADPH.DAM ternary complex over 150-fold (>3 kcal/mol). The dissociation constant of DAM from the (Val31-DHFR). DAM binary complex was too large to be measured fluorometrically. More importantly, these mutations have decreased the overall tight binding of MTX, from 100- to 140-fold (corresponding to a loss of binding energy of 2.2-2.4 kcal/mol) for the Tyr-31 and Val-31 mutants, respectively. These results indicate that hydrophobic interactions between MTX and DHFR are at least as important as formation of the MTX.DHFR salt bridge in the tight binding of MTX.

UR - http://www.scopus.com/inward/record.url?scp=0023860769&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023860769&partnerID=8YFLogxK

U2 - 10.1021/jm00396a019

DO - 10.1021/jm00396a019

M3 - Article

C2 - 3275776

AN - SCOPUS:0023860769

VL - 31

SP - 129

EP - 137

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 1

ER -